Literature DB >> 1204244

The effect of anticomplementary substances on properdin in normal and C2-deficient sera.

R H McLean, K Townsend, A F Michael.   

Abstract

The effect of anticomplementary substances, including zymosan, cobra venom, endotoxin, inulin and immune complexes, on serum properdin concentration and immunoelectrophoretic mobility was studied. In normal serum, zymosan, inulin and immune complexes 'fixed' properdin, while in C2-deficient serum, only zymyosan 'fixed' properdin. Slowly migrating properdin (P) was detected in normal serum following activation by endotoxin and cobra venom but in C2-deficient serum only with cobra venom. Endotoxin did not activate the alternative pathway proteins studied in C2-deficient serum. Fast migrating properdin (P) represented activated properdin and occured as a result of activation of properdin in the Noble agar medium used for electrophoresis provided sufficient cofactors, including Mg2+, were present.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1204244      PMCID: PMC1538159     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Properties of highly purified human properdin.

Authors:  J Ensky; C F Hinz; E W Todd; R J Wedgwood; J T Boyer; I H Lepow
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

2.  Opsonic activity in human serum deficient in C2.

Authors:  F R Johnson; V Agnello; R C Williams
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

3.  The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.

Authors:  A E Stitzel; R E Spitzer
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

4.  Determination of serum properdin levels by immunodiffusion.

Authors:  N G Westberg; R H McLean; A F Michael
Journal:  Int Arch Allergy Appl Immunol       Date:  1973

5.  The immunoelectrophoretic pattern of properdin in fresh and aged human serum.

Authors:  R H McLean; A F Michael
Journal:  Proc Soc Exp Biol Med       Date:  1972-11

6.  C2 deficiency. Development of lupus erythematosus.

Authors:  N K Day; H Geiger; R McLean; A Michael; R A Good
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

7.  Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritis.

Authors:  R H McLean; A F Michael
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

8.  The properdin system and immunity. III. The zymosan assay of properdin.

Authors:  L PILLEMER; L BLUM; I H LEPOW; L WURZ; E W TODD
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

9.  C3 proactivator convertase and its mode of action.

Authors:  H J Müller-Eberhard; O Götze
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

10.  Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.

Authors:  H Gewurz; H S Shin; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  5 in total

1.  Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.

Authors:  B K Davis; T Cavallo
Journal:  Am J Pathol       Date:  1976-08       Impact factor: 4.307

2.  Interactions of radio-detoxified Escherichia coli endotoxin preparations with the complement system.

Authors:  G Füst; L Bertók; S Juhász-Nagy
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

3.  Resolution and analysis of 'native' and 'activated' properdin.

Authors:  T C Farries; J T Finch; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

4.  Mechanisms of activation of the properdin system. Studies on properdin electrophoretic mobility in agarose activation of the alternative pathway.

Authors:  C Adam; D G Williams; D K Peters
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

5.  Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes.

Authors:  A N Theofilopoulos; L H Perrin
Journal:  J Exp Med       Date:  1976-02-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.